Skip to content
  • Thursday, 16 April 2026
  • 5:31 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Pharmaceutical R&D

Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases

Teuku Ryan Apr 16, 2026 0

Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…

Read More
Water-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine ModificationAdvanced NotebookLM Tips & Tricks for Power Users – KDnuggetsRevolutionizing Neuroscience: Andreas Pfenning Unlocks Brain Heterogeneity for Targeted TherapiesScience and armed conflict
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine ModificationLLMOps in 2026: The 10 Tools Every Team Must Have
Unconventional Lithium Sources Discovered in Appalachian Shale Pyrite Could Revolutionize Green Energy Supply ChainsNYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AITerremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare DiseasesScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
YOU MAY HAVE MISSED
Advanced Materials Science
Unconventional Lithium Sources Discovered in Appalachian Shale Pyrite Could Revolutionize Green Energy Supply Chains
Nila Kartika Wati Apr 16, 2026
Clinical Diagnostics & Pathology
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
Reynand Amr Wu Apr 16, 2026
Pharmaceutical R&D
Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Teuku Ryan Apr 16, 2026
Environmental & Analytical Chemistry
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
Abdurrohim Arsyad Apr 16, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ